Clinical Oncology
Volume 19, Issue 4 , Pages 223-227 , May 2007

Three-year Single Institution Audit on Transfusion Requirements in Oncology Patients

  • U. Dernedde

      Affiliations

    • Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UZ, UK
    • Corresponding Author InformationAuthor for correspondence: U. Dernedde, Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UZ, UK. Tel: +44-1603-286286
    • ,
  • R. Dernedde

      Affiliations

    • Im Weedengarten 2, 67271 Battenberg, Germany
    • ,
  • L. Shepstone

      Affiliations

    • University of East Anglia, Norwich NR4 7TJ, UK
    • ,
  • A. Barrett

      Affiliations

    • Norfolk and Norwich University Hospital NHS Trust, Norwich NR4 7UZ, UK

Received 8 November 2005 ,Revised 31 October 2006 ,Accepted 14 November 2006.

References 

  1. Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfus Med. 2003;13:205–218
  2. Seidenfeld J, Piper M, Flamm C, et al. Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials. J Natl Cancer Inst. 2001;93:1204–1214
  3. Rizzo JD, Lichtin AE, Woolf SH, et al. American Society of Clinical Oncology. American Society of Hematology. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002;20:4083–4107
  4. Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer. 2004;40:2201–2216
  5. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Cancer and treatment-related anemia. Version 2, 21 April 2005.
  6. Barrett-Lee PJ, Bailey NP, O'Brien ME, Wager E. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer. 2000;82:93–97
  7. Ludwig H, Barrett-Lee PJ, Gascon P, Schneider M, Van Belle S. European Cancer Anaemia Survey (ECAS) defines factors surrounding anaemia in thousands of adult cancer patients. Proc Am Soc Clin Oncol. 2002;21:abstract 1546
  8. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol. 1997;34(3 Suppl. 2):13–19
  9. Demetri GD, Kris M, Wade J, Degos L, Cella D. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol. 1998;16:3412–3425
  10. Littlewood TJ, Bajetta E, Nortier JWR, et al. Effects of epoitin alfa on haematological parameters and quality of life in cancer patients receiving non-platinum chemotherapy: results of a randomised, double-blind, placebo-controlled trial. J Clin Oncol. 2001;19:2865–2874
  11. Lind M, Vernon C, Cruickshank D, et al. The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer. 2002;86:1243–1249
  12. Skillings JR, Sridhar FG, Wong C, Paddock L. The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study. Am J Clin Oncol. 1993;16:22–25
  13. Heddens D, Alberts D, Hannigan EV, et al. Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment. Gynecol Oncol. 2002;86:239–243
  14. Coiffier B, Guastalla JP, Pujade-Lauraine E, Bastit P. Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey. Eur J Cancer. 2001;37:1617–1623
  15. Groopman JE, Loretta MI. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst. 1999;91:1616–1634
  16. Abels RI. Recombinant human erythropoietin in the treatment of the anaemia of cancer. Acta Haematol. 1992;87(Suppl. 1):4–11
  17. Shasha D, Harrison LB. Anemia treatment and the radiation oncologist: optimizing patient outcomes. Oncology. 2001;15:1486–1496
  18. Seshadri T, Prince HM, Bell DR, et al. The Australian Cancer Anaemia Survey: a snapshot of anaemia in adult patients with cancer. Med J Aust. 2005;182:453–457
  19. Murphy MF, Wallington TB, Kelsey P, et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the clinical use of red cell transfusions. Br J Haematol. 2001;113:24–31
  20. Thatcher N, De Campos ES, Bell DR, et al. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer. 1999;80:396–402
  21. Drugs and Therapeutics Bulletin . Epoitins and darbepoetin alfa in malignant disease. DTB. 2004;42:21–23

PII: S0936-6555(06)00425-0

doi: 10.1016/j.clon.2006.11.011

Clinical Oncology
Volume 19, Issue 4 , Pages 223-227 , May 2007

Article Tools

* Image Usage & Resolution